CLARKE NEUMANN
CIK 1321466 · See Remarks · last filed 2024-08-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
41
Lifetime Open-Market Net
-$101.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (BIOR) Delisted | See Remarks | 465,564 | $0.22 | $102.4K | $0 | 10 | 2024-08-16 |
| BIORA THERAPEUTICS, INC. (PROG) Delisted | See Remarks | 316,625 | $0.88 | $280.1K | $0 | 11 | 2022-04-19 |
| SEQUENOM INC (SQNM) Delisted | VP & General Counsel | 21,907 | — | — | -$101.9K | 20 | 2012-02-08 |
Recent Filings · Page 5 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-01-22 | SEQUENOM INC (SQNM) Delisted | Grant (A) | +5,044 | $0 | EDGAR |
Showing 41–41 of 41
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.